| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Marie-Bernadette Delisle | Q40381347 |
| Franck Bourdeaut | Q66360615 | ||
| Christelle Dufour | Q90394646 | ||
| P2093 | author name string | Torsten Pietsch | |
| Nicolas Sevenet | |||
| Catherine Miquel | |||
| Aurore Siegfried | |||
| Annick Sevely | |||
| Camille Grison | |||
| Najat Loukh | |||
| Anne Isabelle Bertozzi | |||
| Delphine Lafon | |||
| P2860 | cites work | Molecular subgroups of medulloblastoma: the current consensus | Q24615271 |
| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition | Q27852966 | ||
| Subgroup-specific structural variation across 1,000 medulloblastoma genomes | Q28271811 | ||
| Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease | Q28288622 | ||
| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
| Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective | Q34605276 | ||
| Rapid diagnosis of medulloblastoma molecular subgroups | Q34764793 | ||
| The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma | Q35993240 | ||
| Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups | Q36460209 | ||
| Molecular diagnostics in embryonal brain tumors | Q36619093 | ||
| Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
| Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma | Q36929844 | ||
| Signaling pathway and molecular subgroups of medulloblastoma | Q36956174 | ||
| Medulloblastoma-translating discoveries from the bench to the bedside | Q38263111 | ||
| The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
| Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis | Q39828521 | ||
| Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations | Q42468615 | ||
| High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. | Q42504937 | ||
| MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma | Q43553178 | ||
| Implications of tumor location on subtypes of medulloblastoma. | Q44021901 | ||
| Treatment of early childhood medulloblastoma by postoperative chemotherapy alone | Q46367739 | ||
| Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior | Q48227672 | ||
| Expression of p75NTR in fetal brain and medulloblastomas: evidence of a precursor cell marker and its persistence in neoplasia | Q48807684 | ||
| Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. | Q55462103 | ||
| MRI features in children with desmoplastic medulloblastoma. | Q55462367 | ||
| Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer | Q73614016 | ||
| High-throughput simultaneous detection of point mutations and large-scale rearrangements by CE | Q81569442 | ||
| P433 | issue | 3 | |
| P921 | main subject | medulloblastoma | Q1333608 |
| P304 | page(s) | 106-113 | |
| P577 | publication date | 2016-02-09 | |
| P1433 | published in | Clinical Neuropathology | Q15763518 |
| P1476 | title | Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature | |
| P478 | volume | 35 |
| Q98386752 | A Retrospective Analysis of the Demographics, Treatment, and Survival Outcomes of Patients with Desmoplastic Nodular Medulloblastoma Using the Surveillance, Epidemiology, and End Results (SEER) Database |
| Q49548506 | Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk and prognosis. |
Search more.